{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:46:43Z","timestamp":1792882003494,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["RG-34\u2013166\u201343"],"award-info":[{"award-number":["RG-34\u2013166\u201343"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bioorg.2022.106309","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:55:27Z","timestamp":1670248527000},"page":"106309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX\/XII inhibitors: A new regioisomerism tactic"],"prefix":"10.1016","volume":"131","author":[{"given":"Afaf","family":"El-Malah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab S.","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar S.","family":"Elbaramawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2022.106309_b0005","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2022.106309_b0010","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/14756366.2021.1972995","article-title":"An overview on the recently discovered iota-carbonic anhydrases","volume":"36","author":"Nocentini","year":"2021","journal-title":"J. Enzym. Inh. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2022.106309_b0020","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2174\/138161210793429797","article-title":"Carbonic anhydrase inhibition\/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets","volume":"16","author":"Supuran","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2022.106309_b0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/cryst10030171","article-title":"A novel Ag-N heterocyclic carbene complex bearing the hydroxyethyl ligand: synthesis, characterization, crystal and spectral structures and bioactivity properties","volume":"10","author":"Aktas","year":"2020","journal-title":"Crystals"},{"key":"10.1016\/j.bioorg.2022.106309_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103762","article-title":"I. Gul\u00e7in Novel functionally substituted esters based on sodium diethyldithiocarbamate derivatives: synthesis, characterization, biological activity and molecular docking studies","volume":"99","author":"Karimov","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0035","article-title":"Synthesis of water-soluble tetra-substituted phthalocyanines: investigation of DNA cleavage, cytotoxic effects and metabolic enzyme inhibition","volume":"214","author":"G\u00fcnsel","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2022.106309_b0040","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2022.106309_b0045","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3390\/cancers14143297","article-title":"Cancer therapeutic targeting of hypoxia induced carbonic anhydrase IX: from bench to bedside","volume":"14","author":"McDonald","year":"2022","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bioorg.2022.106309_b0050","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2022.106309_b0055","doi-asserted-by":"crossref","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Can. J. Clin. 71 (2021) 209-249. https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"10.1016\/j.bioorg.2022.106309_b0060","doi-asserted-by":"crossref","unstructured":"F. Bray, J. Ferlay, I. Soerjomataram, R. L Siegel, L. A. Torre, A. Jemal. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Can. J. Clin. 68 (2018) 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","DOI":"10.3322\/caac.21492"},{"key":"10.1016\/j.bioorg.2022.106309_b0065","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/bmm.15.78","article-title":"Therapeutic drug monitoring of targeted anticancer therapy","volume":"9","author":"Decosterd","year":"2015","journal-title":"Biomark. Med."},{"key":"10.1016\/j.bioorg.2022.106309_b0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejps.2019.01.028","article-title":"Towards modern anticancer agents that interact with tubulin","volume":"131","author":"La Regina","year":"2019","journal-title":"Eur J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2022.106309_b0075","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.ejca.2005.09.011","article-title":"The role of carbonic anhydrase IX overexpression in kidney cancer","volume":"41","author":"Dorai","year":"2005","journal-title":"Eur. J. Can."},{"key":"10.1016\/j.bioorg.2022.106309_b0080","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","author":"Robertson","year":"2004","journal-title":"Can. Res."},{"key":"10.1016\/j.bioorg.2022.106309_b0085","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1006\/bbrc.2001.5824","article-title":"The catalytic properties of human carbonic anhydrase IX","volume":"288","author":"Wingo","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2022.106309_b0090","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-07-6151","article-title":"Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer","volume":"68","author":"Barnett","year":"2008","journal-title":"Can. Res."},{"key":"10.1016\/j.bioorg.2022.106309_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/453543","article-title":"Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors","author":"Pinard","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bioorg.2022.106309_b0100","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/14756366.2020.1801674","article-title":"Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents","volume":"35","author":"Krasavin","year":"2020","journal-title":"J. Enzym. Inh. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0105","doi-asserted-by":"crossref","unstructured":"C.T., Supuran, Inhibition of carbonic anhydrase IX as a novel anticancer mechanism. World J. of Clin. Oncol. 3 (2012) 98-103. https:\/\/dx.doi.org\/10.5306\/wjco.v3.i7.98.","DOI":"10.5306\/wjco.v3.i7.98"},{"key":"10.1016\/j.bioorg.2022.106309_b0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JEP.S265620","article-title":"Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors","volume":"12","author":"Supuran","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106309_b0115","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.3390\/ijms22116098","article-title":"Inhibition of carbonic anhydrase IX promotes apoptosis through intracellular pH level alterations in cervical cancer cells","volume":"22","author":"Temiz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2022.106309_b0120","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","article-title":"Quinoline: a promising antitubercular target","volume":"68","author":"Keri","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2022.106309_b0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.drudis.2012.11.003","article-title":"Quinolines: a new hope against inflammation","volume":"18","author":"Mukherjee","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2022.106309_b0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/5584_2019_428","article-title":"Quinolines and quinolones as antibacterial, antifungal, anti-virulence, antiviral and anti-parasitic agents","volume":"1282","author":"Senerovic","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bioorg.2022.106309_b0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11030-019-09953-4","article-title":"Insights into the current status of privileged N-heterocycles as antileishmanial agents","volume":"24","author":"Razzaghi-Asl","year":"2020","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2022.106309_b0140","article-title":"Recent contributions of quinolines to antimalarial and anticancer drug discovery research","volume":"266","author":"Van de Walle","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0145","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/molecules24071274","article-title":"New quinoline-based heterocycles as anticancer agents targeting Bcl-2","volume":"24","author":"Hamdy","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2022.106309_b0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/ph13110393","article-title":"Potent quinoline-containing combretastatin A-4 analogues: design, synthesis, antiproliferative, and anti-tubulin activity","volume":"13","author":"Ibrahim","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2022.106309_b0155","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1021\/acs.jmedchem.8b01938","article-title":"Discovery and mechanistic study of tailor-made quinoline derivatives as topoisomerase 1 poison with potent anticancer activity","volume":"62","author":"Kundu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0160","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/ph15050494","article-title":"Uracil as a Zn-binding bioisostere of the allergic benzenesulfonamide in the design of quinoline-uracil hybrids as anticancer carbonic anhydrase inhibitors","volume":"15","author":"El-Kalyoubi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2022.106309_b0165","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/bjc.2014.508","article-title":"Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study","volume":"111","author":"Isakoff","year":"2014","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.bioorg.2022.106309_b0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17460441.2017.1319357","article-title":"An overview of quinoline as a privileged scaffold in cancer drug discovery","volume":"12","author":"Musiol","year":"2017","journal-title":"Expert. Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2022.106309_b0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejmech.2017.05.027","article-title":"Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance","volume":"142","author":"Patel","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000011923","article-title":"Topotecan- A novel topoisomerase I inhibitor: pharmacology and clinical experience","volume":"56","author":"Kollmannsberger","year":"1999","journal-title":"Oncology."},{"key":"10.1016\/j.bioorg.2022.106309_b0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphys.2018.00167","article-title":"Antineoplastic drug-induced cardiotoxicity: a redox perspective","volume":"9","author":"Varricchi","year":"2018","journal-title":"Front Physiol."},{"key":"10.1016\/j.bioorg.2022.106309_b0190","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1111\/bph.13189","article-title":"Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer","volume":"172","author":"To","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106309_b0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/13543784.12.2.283","article-title":"Indisulam: an anticancer sulfonamide in clinical development","volume":"12","author":"Supuran","year":"2003","journal-title":"Expert. Opin. Investig. Drugs."},{"key":"10.1016\/j.bioorg.2022.106309_b0205","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumours","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2022.106309_b0210","doi-asserted-by":"crossref","first-page":"e92928","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI Insight."},{"key":"10.1016\/j.bioorg.2022.106309_b0215","doi-asserted-by":"crossref","unstructured":"T. C. S. Ho, A. H. Y. Chan, A. Ganesan. Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight. J. Med. Chem. 63 (2020) 12460-12484.","DOI":"10.1021\/acs.jmedchem.0c00830"},{"key":"10.1016\/j.bioorg.2022.106309_b0220","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd.2016.253","article-title":"From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors","volume":"16","author":"Ashkenazi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2022.106309_b0225","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1021\/acs.jmedchem.5b01888","article-title":"Expanding the cancer arsenal with targeted therapies: disarmament of the antiapoptotic Bcl-2 proteins by small molecules","volume":"60","author":"Yap","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0230","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: a critical review","volume":"162","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0235","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/14756366.2019.1652282","article-title":"Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino) benzenesulfonamidesAQ3 as carbonic anhydrase isoforms I and II inhibitors","volume":"34","author":"Al-Sanea","year":"2019","journal-title":"J. Enzym. Inhib Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0240","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1080\/14756366.2019.1626376","article-title":"Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors","volume":"34","author":"Thacker","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0245","doi-asserted-by":"crossref","first-page":"11119","DOI":"10.3390\/ijms222011119","article-title":"Development of novel quinoline-based sulfonamides as selective cancer-associated carbonic anhydrase isoform IX inhibitors","volume":"22","author":"Shaldam","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2022.106309_b0250","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756369909030332","article-title":"Carbonic anhydrase inhibitors. Schiff bases of some aromatic sulfonamides and their metal complexes: towards more selective inhibitors of carbonic anhydrase isozyme IV","volume":"14","author":"Popescu","year":"1999","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.bioorg.2022.106309_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103782","article-title":"Design, synthesis, and biological evaluation of novel 5-((substituted quinolin-3-yl\/1-naphthyl) methylene)-3-substituted imidazolidin-2,4-dione as HIV-1 fusion inhibitors","volume":"99","author":"Ibrahim","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113457","article-title":"Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition","volume":"219","author":"Ghanim","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0265","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1039\/C7MD00526A","article-title":"Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy","volume":"9","author":"Malik","year":"2017","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bioorg.2022.106309_b0270","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ccr.2019.03.010","article-title":"Recent developments in penta-, hexa- and heptadentate Schiff base ligands and their metal complexes","volume":"389","author":"Liu","year":"2019","journal-title":"Coordination Chemistry Reviews"},{"key":"10.1016\/j.bioorg.2022.106309_b0275","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0280","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm501573b","article-title":"Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties","volume":"58","author":"Bozta\u015f","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0285","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11307-015-0885-x","article-title":"Evaluation of CAIX and CAXII expression in breast cancer at varied O2 levels: CAIX is the superior surrogate imaging biomarker of tumor hypoxia","volume":"18","author":"Tafreshi","year":"2016","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.bioorg.2022.106309_b0290","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods."},{"key":"10.1016\/j.bioorg.2022.106309_b0295","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","article-title":"Apoptosis, autophagy, necroptosis, and cancer metastasis","volume":"14","author":"Su","year":"2015","journal-title":"Mol. Cancer."},{"key":"10.1016\/j.bioorg.2022.106309_b0300","first-page":"3448","article-title":"Crosstalk between apoptosis, necrosis and autophagy","volume":"2013","author":"Nikoletopoulou","year":"1833","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.bioorg.2022.106309_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2014.12.018","article-title":"Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target","volume":"94","author":"Radogna","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106309_b0310","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.1117105","article-title":"Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis","volume":"310","author":"Spierings","year":"2005","journal-title":"Science."},{"key":"10.1016\/j.bioorg.2022.106309_b0315","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/cells11010110","article-title":"Mitochondrial dysfunction as a hallmark of environmental injury","volume":"11","author":"Duarte-Hospital","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.bioorg.2022.106309_b0320","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","article-title":"Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations","volume":"59","author":"Nocentini","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0325","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0330","doi-asserted-by":"crossref","unstructured":"D.A. hittington, A. Waheed, B. Ulmasov, G.N. Shah, J.H. Grubb, W.S. Sly, D.W. Christianson, Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells, Proc. Natl. Acad. Sci. USA. 98 (2001) 9545-9550. https:\/\/doi.org\/10.1073\/pnas.161301298.","DOI":"10.1073\/pnas.161301298"},{"key":"10.1016\/j.bioorg.2022.106309_b0335","first-page":"1419","article-title":"Enantioselective synthesis of substituted 3-quinolyl alkanols and their application to asymmetric autocatalysis","volume":"9","author":"Sato","year":"2004","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2022.106309_b0340","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/cjoc.200990224","article-title":"Highly efficient N-monomethylation of primary aryl amines","volume":"27","author":"Peng","year":"2009","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.bioorg.2022.106309_b0345","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bmcl.2012.11.006","article-title":"Synthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives","volume":"23","author":"Zhang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106309_b0350","doi-asserted-by":"crossref","unstructured":"T.S. Ibrahim, M.M. Hawwas, E.S. Taher, N.A. Alhakamy, M.A. Alfaleh, M. Elagawany M.B. Elgendy, G.M. Zayed, M.F.A. Mohamed, Z.K. Abdel-Samii, Y.A.M.M. Elshaier. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy, Bioorg. Chem. 105 (2020) 104352. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104352.","DOI":"10.1016\/j.bioorg.2020.104352"},{"key":"10.1016\/j.bioorg.2022.106309_b0355","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ardp.19803130209","article-title":"Structure dependance of antiplasmodic activity of 3-[N-(4-amidosulfonylphenyl)aminomethyl]-quinoline","volume":"313","author":"Gaedcke","year":"1980","journal-title":"Arch. Pharm. Chem. Life Sci. (Weinheim)"},{"key":"10.1016\/j.bioorg.2022.106309_b0360","doi-asserted-by":"crossref","first-page":"20882","DOI":"10.1021\/acsomega.9b01474","article-title":"Molecular and cellular response of co-cultured cells toward cobalt chloride (CoCl2)-induced hypoxia","volume":"4","author":"Tripathi","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2022.106309_b0365","unstructured":"RCSB Protein Data Bank (PDB) http:\/\/www.rcsb.org\/pdb."},{"key":"#cr-split#-10.1016\/j.bioorg.2022.106309_b0370.1","unstructured":"Molecular Operating Environment (MOE 2019.0102) Chemical Computing Group Inc, Montreal Quebec Canada"},{"key":"#cr-split#-10.1016\/j.bioorg.2022.106309_b0370.2","unstructured":"http:\/\/www.chemcomp.com. 2019.0102."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822007155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822007155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:40:05Z","timestamp":1758616805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822007155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":75,"alternative-id":["S0045206822007155"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106309","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX\/XII inhibitors: A new regioisomerism tactic","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106309"}}